These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2502790)

  • 41. Possible mechanism of adverse reaction following levodopa plus benserazide treatment.
    Messiha FS
    Br J Pharmacol; 1977 May; 60(1):55-7. PubMed ID: 884390
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Levodopa pharmacokinetics. Alterations after benserazide, a decarboxylase inhibitor.
    Doller HJ; Connor JD; Lock DR; Sloviter RS; Dvorchik BH; Vesell ES
    Drug Metab Dispos; 1978; 6(2):164-8. PubMed ID: 26532
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A neuroanatomical substrate for alcohol drinking: identification of tetrahydropapaveroline (THP)-reactive sites in the rat brain.
    Myers RD; Privette TH
    Brain Res Bull; 1989 May; 22(5):899-911. PubMed ID: 2765949
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The mixed 5-HT 1A/2A receptor drug FG5938 suppresses alcohol drinking while enhancing feeding in P rats.
    Piercy KT; Björk AK; Myers RD
    Alcohol; 1996; 13(5):521-7. PubMed ID: 8888950
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Locomotor response to L-DOPA in reserpine-treated rats following central inhibition of aromatic L-amino acid decarboxylase: further evidence for non-dopaminergic actions of L-DOPA and its metabolites.
    Alachkar A; Brotchie JM; Jones OT
    Neurosci Res; 2010 Sep; 68(1):44-50. PubMed ID: 20542064
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Action of anorexigenic peptide injected into the brain: dissociation of effect on body weight and feeding in the rat.
    Myers RD; Hepler JR; Holahan W
    Peptides; 1983; 4(1):85-8. PubMed ID: 6866812
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Anatomical mapping of tetrahydropapaveroline-reactive sites in brain mediating suppression of alcohol drinking in the rat.
    Privette TH; Myers RD
    Brain Res Bull; 1989 Jun; 22(6):1039-48. PubMed ID: 2790497
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alcohol drinking induced in the monkey by tetrahydropapaveroline (THP) infused into the cerebral ventricle.
    Myers RD; McCaleb ML; Ruwe WD
    Pharmacol Biochem Behav; 1982 Jun; 16(6):995-1000. PubMed ID: 7111356
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyanamide on ethanol intake: how does it really work?
    Aragon CM; Spivak K; Smith BR; Amit Z
    Alcohol Alcohol; 1993 Jul; 28(4):413-21. PubMed ID: 8397523
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Benserazide decreases central AADC activity, extracellular dopamine levels and levodopa decarboxylation in striatum of the rat.
    Jonkers N; Sarre S; Ebinger G; Michotte Y
    J Neural Transm (Vienna); 2001; 108(5):559-70. PubMed ID: 11459076
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Intracerebroventricular morphine enhances alcohol consumption by rats.
    Linseman MA; Harding S
    Pharmacol Biochem Behav; 1990 Jun; 36(2):405-8. PubMed ID: 2356215
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intracerebroventricularly infused angiotensin II or III do not alter voluntary alcohol intake in rats.
    Grupp LA; Harding S
    Pharmacol Biochem Behav; 1995 Aug; 51(4):593-9. PubMed ID: 7675830
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Alcohol drinking in the rat: increases following intracerebroventricular treatment with tetrahydro-beta-carbolines.
    Tuomisto L; Airaksinen MM; Peura P; Eriksson CJ
    Pharmacol Biochem Behav; 1982 Oct; 17(4):831-6. PubMed ID: 7178191
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The action L-dopa on sexual behaviour of male rats.
    Da Prada M; Carruba M; Saner A; O'Brien A; Pletscher A
    Brain Res; 1973 Jun; 55(2):383-9. PubMed ID: 4541349
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of cyanamide on body weight and brain monoamines and metabolites in rats.
    Obach R; Menargues A; Vallès J; Vallès JM; García-Sevilla JA
    Eur J Pharmacol; 1986 Aug; 127(3):225-31. PubMed ID: 3758181
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Tolerance to disulfiram induced by chronic alcohol intake in the rat.
    Tampier L; Quintanilla ME; Israel Y
    Alcohol Clin Exp Res; 2008 Jun; 32(6):937-41. PubMed ID: 18445101
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Skeletal changes induced by dopa decarboxylase inhibitor in rats.
    Tanaka C; Tanaka S; Itokawa Y; Takaori S
    Jpn J Pharmacol; 1973 Feb; 23(1):123-5. PubMed ID: 4541614
    [No Abstract]   [Full Text] [Related]  

  • 58. Benserazide dosing regimen affects the response to L-3,4-dihydroxyphenylalanine in the 6-hydroxydopamine-lesioned rat.
    Tayarani-Binazir KA; Jackson MJ; Strang I; Jairaj M; Rose S; Jenner P
    Behav Pharmacol; 2012 Apr; 23(2):126-33. PubMed ID: 22236652
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Extracellular concentrations of dopamine and metabolites in the rat caudate after oral administration of a novel catechol-O-methyltransferase inhibitor Ro 40-7592.
    Acquas E; Carboni E; de Ree RH; Da Prada M; Di Chiara G
    J Neurochem; 1992 Jul; 59(1):326-30. PubMed ID: 1613509
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Increased neostriatal dopamine activity after intraperitoneal or intranasal administration of L-DOPA: on the role of benserazide pretreatment.
    Silva MA; Mattern C; Häcker R; Tomaz C; Huston JP; Schwarting RK
    Synapse; 1997 Dec; 27(4):294-302. PubMed ID: 9372552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.